HIGHLIGHTS
- who: Rafael Paternostro from the Divison of Gastroenterology and Hepatology, Department of Medicine III, Medical University of, Waehringer Guertel, Austria have published the research work: The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices, in the Journal: (JOURNAL)
- what: Aim of the study is to investigate (i) NSBB-response rates in primary- and secondary prophylaxis of variceal bleeding and_(ii) the impact of NSBB-response on clinical outcomes in patients with NASH cirrhosis. were excluded from the study. The study provides information on the potential prognostic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.